Enerpac Tool Group NYSE: EPAC said its fiscal third quarter showed mid-single-digit growth in its core product business and improving sequential trends in services, while management highlighted a planned acquisition that would expand the company's exposure to power generation, defense, semiconductors and data centers.
Enerpac (EPAC) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.51 per share a year ago.
Investors need to pay close attention to EPAC stock based on the movements in the options market lately.
| Machinery Industry | Industrials Sector | Paul E. Sternlieb CEO | XDUS Exchange | US2927651040 ISIN |
| US Country | 2,000 Employees | 7 Oct 2025 Last Dividend | 9 Nov 2007 Last Split | 24 Jul 2000 IPO Date |
Enerpac Tool Group Corp., originally founded in 1910 and headquartered in Menomonee Falls, Wisconsin, stands as a prolific provider of industrial products and solutions on a global scale, including in the United States, the United Kingdom, Germany, Australia, Canada, China, Saudi Arabia, Brazil, France, among other international markets. It caters to a wide range of industries through its Industrial Tools & Services and Other segments, underscoring its pivotal role in various key markets such as infrastructure, maintenance, oil and gas, mining, and renewable energy sectors. Initially known as Actuant Corporation, the company underwent a rebranding to Enerpac Tool Group Corp. in January 2020, signifying a focused pivot towards its core strengths in high-force tools and controlled force products and services.
Enerpac Tool Group Corp. delivers a comprehensive suite of products and services designed to meet the diverse needs of several vital industries:
Marketed primarily under the Enerpac, Hydratight, Larzep, and Simplex brands, these products and services play a pivotal role in numerous markets, including oil and gas, mining, and renewable energy, to name a few. Additionally, the company's Other segment delivers innovation through the design and manufacture of synthetic ropes and biomedical textiles, underlining its diversification into adjacent markets.